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A B S T R A C T
Edwardsiella tarda (E. tarda) is a rare human pathogen; however, the overall mortality of bacteremia is
reported to be up to 50%. Here, we describe a case of cholangitis with E. tarda bacteremia who had a
pancreatoduodenectomy for a locally advanced gastric cancer. He was successfully treated using a
cefmetazole, a second generation cephalosporin for 14days. To the best of our knowledge, this is the ﬁrst
case report about E. tarda bacteremia after biliary reconstruction.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Edwardsiella tarda (E. tarda) is an unusual human pathogen that
can cause gastroenteritis, soft tissue infection, myonecrosis,
bacteremia, cholecystitis, liver abscess, osteomyelitis, and tuboo-
varian abscess [1–4]. The most frequent manifestation is gastro-
enteritis and the least frequent is extra-intestinal infection.
Immunocompromised patients are more vulnerable to infection
and their mortality rate is reported to be about 50% when
associated with bacteremia [1,5]. This article describes a case of a
metastatic gastric cancer patient infected with E. tarda bacteremia
who was successfully treated with antimicrobials.
Case presentation
A 78year old man came to hour hospital complaining of a high
grade fever and a shaking chill. He has undergone a pancreato-
duodenectomy for a locally advanced gastric cancer two years
before, and a liver metastasis was found three months after
surgery. His body temperature was 39.1 C and his abdomen was
not painful. The patient was diagnosed with retrograde cholangitis
on the basis of his recurrent episodes of cholangitis after surgery
and having liver function enzymes elevated beyond normal range.
We begun antimicrobial therapy with cefmetazole. E. tarda was
identiﬁed from the blood culture as a causative agent and it was
discovered that he had eaten raw seafood two days before his
admission day (Chart 1). After 14 days of antimicrobial therapy he
was discharged without any complications.
Discussion
E. tarda is a nonfermenting gram-negative bacilli which is
identiﬁed apart from Salmonella species for producing hydrogen
sulﬁde and indole; and also fermenting only glucose and maltose.
It is a member of Eneterobacteriaceae, but rarely colonizes in the
human gastrointestinal tract, reported to be found only in 26 of
353,600 Japanese individuals [6]. They are commonly isolated
from fresh water environments and habituating animals such as
ﬁsh and reptiles. Contact with these animals and consumption of
contaminated food, e.g., sushi, raw ﬁsh, and raw meat, are
considered as risk factors of E. tarda infection [4,5,7,8]. Hirai
et al. showed that 45.5% of cases of bacteremia have been reported
in Japan, where many brackish water areas and rivers are found
and much raw seafood is eaten. They also studied the seasonal
distribution of all patients infected with E tarda; 77.2% of
bacteremia occurred between July and November [5]. Other well
established risk factors of the host are hepatobiliary diseases,
malignancy, and diabetes mellitus [9].
Our patient had a clinical history of developing a liver
metastasis of the gastric cancer, and an episode of having eaten
sushi in July. In addition, he had undergone a pancreatoduodnec-
toymy and biliary reconstruction which may have allowed the
bacteria to more easily enter bloodstream from the intestines.
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Once bacteremia has occurred, the mortality ranges from 40 to
50%, [1,5,9] regardless of its sensitivity to antimicrobials. In the
literature, penicillins, cephalosporins and carbapenems are often
utilized. Our patient had a recurrent episode of retrograde
cholangitis caused by Escherichia coli with extended spectrum
beta lactamase. Based on the evidence that cephamycin is effective
against extended spectrum beta lactamase producing Enter-
obacteriaceae [10], we begun the antimicrobial treatment with
cefmetazole and were successful.
Conclusion
A liver metastatic gastric cancer patient with E. tarda
bacteremia was treated successfully with cefmetazole, a second
generation cephalosporin. To the best of our knowledge, this is the
ﬁrst case report about E. tarda bacteremia after pancreatoduode-
nectomy.
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Chart 1. Note that this is two separate graphs, with the hospital day shown on the horizontal axis. The upper part shows temperature in the straight line andwhite blood cell
count in the interrupted line. The lower half of this ﬁgure shows alkaline phosphatase in the straight line, aspartate aminotransferase in the interrupted line and alanine
aminotransferase in the dashed line. Along the top, the antibiotic therapy that was given through the hospital course. As shown here, his body temperature and white blood
cell count was normalized on admission day 4 when a Gram negative rod was identiﬁed from blood culture. Antimicrobial therapy with cefmetazole was thought successful
and continued for 14days.
K. Nishida et al. / IDCases 5 (2016) 76–77 77
